...
首页> 外文期刊>Journal of the American Academy of Dermatology >Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
【24h】

Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.

机译:尚无证据证明默克尔细胞多瘤病毒在具有免疫功能的默克尔细胞癌患者中感染了基底细胞或鳞状细胞癌。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Merkel cell polyomavirus (MCV) was discovered by digital transcriptome subtraction as a monoclonal infection of Merkel cell carcinoma (MCC) tumors. Subsequent studies have repeatedly confirmed that MCV is the likely cause for most MCC. Polymerase chain reaction-based detection of the virus in other nonmelanoma skin cancers, however, has been inconsistent and controversial. OBJECTIVE: We sought to directly assay for MCV infection in squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) tumor cells by immunostaining for viral antigen. METHODS: CM2B4, a monoclonal antibody to exon 2 peptides of MCV T antigen, was used to examine tumors from 20 patients with MCC with and without secondary SCC or BCC tumors. RESULTS: MCV T antigen was readily detected in 15 (75%) of 20 MCC tumors including 11 MCC tumors from patients with secondary SCC or BCC. In contrast to MCC, none of these secondary BCC or SCC was MCV T-antigen positive. LIMITATIONS: A limitation was the small study size with antigen detection including only the MCV large T and 57kT proteins. CONCLUSIONS: MCV T antigen is generally not expressed in BCC or SCC tumors from a population favored to have MCV infection, ie, those persons already given the diagnosis of MCV-positive MCC. This suggests that episodic polymerase chain reaction detection of MCV genome in BCC or SCC tumors may represent coincidental rather than causal infection, and that these tumors share other noninfectious risk factors.
机译:背景:通过数字转录组减法发现默克尔细胞多瘤病毒(MCV)是默克尔细胞癌(MCC)肿瘤的单克隆感染。随后的研究反复证实,MCV是大多数MCC的可能原因。然而,在其他非黑素瘤皮肤癌中,基于聚合酶链反应的病毒检测一直存在争议。目的:我们试图通过对病毒抗原进行免疫染色来直接检测鳞状细胞癌(SCC)或基底细胞癌(BCC)肿瘤细胞中的MCV感染。方法:CM2B4是MCV T抗原第2外显子的单克隆抗体,用于检查20例患有和不患有继发性SCC或BCC肿瘤的MCC患者的肿瘤。结果:在患有继发性SCC或BCC的20例MCC肿瘤中,有15例(75%)容易检测出MCV T抗原,其中包括11例MCC肿瘤。与MCC相反,这些继发性BCC或SCC都不是MCV T抗原阳性的。局限性:局限性在于抗原检测的研究规模很小,仅包括MCV大T和57kT蛋白。结论:MCV T抗原通常在倾向于感染MCV的人群(即已经被诊断出MCV阳性MCC的人)的BCC或SCC肿瘤中不表达。这表明在BCC或SCC肿瘤中MCV基因组的阵发聚合酶链反应检测可能代表了巧合,而不是因果关系感染,并且这些肿瘤具有其他非感染性危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号